What Is Volbella XC and How It Works for Lips
Volbella XC is a hyaluronic acid dermal filler specifically approved by the U.S. Food and Drug Administration for lip augmentation and the correction of perioral lines, also known as smoker's lines, around the mouth. It is manufactured by Allergan Aesthetics, a subsidiary of AbbVie, and was approved by the FDA in 2016 for these specific indications. The formulation uses a proprietary Vycross technology that creates a smooth, cohesive gel designed to integrate with the lip tissue while maintaining natural flexibility and softness.
The active ingredient in Volbella XC is hyaluronic acid, a naturally occurring substance in the body that attracts and retains moisture. The filler is formulated with a lower concentration of hyaluronic acid and a higher degree of cross-linking compared to other fillers, which gives it a smoother consistency and a more subtle, natural-looking result when injected into the lips. It is intended for fine to moderate facial wrinkles and lines and for lip volume augmentation, with clinical trials demonstrating high patient satisfaction rates for both lip enhancement and the smoothing of lines around the mouth.
Volbella XC Cost, Longevity, and Clinical Results
The average cost of a single syringe of Volbella XC in the United States ranges from approximately $600 to $1,200, depending on the geographic location, the provider's expertise, and the amount of product required. Most patients require one to two syringes per treatment session for lip augmentation, and the total cost can vary based on the clinic's pricing structure and any additional fees for the procedure. The results from a single treatment can last up to one year for lip augmentation and up to 12 months for the correction of perioral lines, according to Allergan's clinical data and real-world treatment observations.
Clinical studies have shown that Volbella XC provides a high rate of patient satisfaction, with studies reporting that a significant majority of patients rated their lip augmentation results as improved at 52 weeks post-treatment. The Vycross technology used in Volbella XC is also found in other Allergan fillers like Juvederm Voluma XC, but Volbella XC is specifically optimized for the delicate lip area with a smoother, more refined gel structure. This formulation is designed to minimize swelling and bruising compared to some other hyaluronic acid fillers, contributing to a more comfortable recovery experience and a more predictable aesthetic outcome.
Comparing Volbella XC to Other Lip Fillers and Finding a Provider
When compared to other hyaluronic acid fillers used for lip augmentation, such as Juvederm Ultra XC and Restylane Silk, Volbella XC is distinguished by its Vycross technology, which provides a smoother, more cohesive gel that integrates well with lip tissue. Juvederm Ultra XC also uses hyaluronic acid and is FDA-approved for lip augmentation, with results typically lasting up to one year, while Restylane Silk is specifically designed for lip enhancement and the smoothing of lines around the mouth. Each filler has a distinct formulation, and the choice between them often depends on the specific aesthetic goals of the patient and the injector's assessment of the lip structure and desired outcome.
To find a qualified provider for Volbella XC injections, patients are advised to seek board-certified dermatologists or plastic surgeons who have specific training and experience with hyaluronic acid fillers for lip augmentation. The official Allergan Aesthetics website provides a provider locator tool that can help identify certified injectors in a specific area, and patients should verify a provider's credentials and experience with the specific product before scheduling a consultation. The American Society of Plastic Surgeons and the American Academy of Dermatology also offer resources for finding qualified specialists, and patients should discuss their medical history, any medications they are taking, and their aesthetic goals during a thorough consultation to determine if Volbella XC is the appropriate treatment option for their needs.